UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1157) 1157
Newsletter (22) 22
Magazine Article (21) 21
Book Chapter (5) 5
Conference Proceeding (4) 4
Newspaper Article (3) 3
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
liraglutide (982) 982
science & technology (918) 918
life sciences & biomedicine (891) 891
humans (643) 643
animals (439) 439
male (423) 423
diabetes mellitus, type 2 - drug therapy (396) 396
glucagon-like peptide 1 - analogs & derivatives (386) 386
type 2 diabetes (363) 363
pharmacology & pharmacy (361) 361
diabetes (322) 322
hypoglycemic agents - therapeutic use (316) 316
liraglutide - pharmacology (314) 314
hypoglycemic agents - pharmacology (308) 308
endocrinology & metabolism (279) 279
glucagon (251) 251
female (246) 246
glucagon-like peptide 1 - pharmacology (237) 237
liraglutide - therapeutic use (214) 214
mice (187) 187
glucagon-like peptide 1 - therapeutic use (182) 182
obesity (179) 179
middle aged (175) 175
exenatide (173) 173
glucose (170) 170
peptides (167) 167
insulin (160) 160
diabetes mellitus (156) 156
analysis (150) 150
glucagon-like peptide-1 receptor - agonists (149) 149
research (140) 140
rats (137) 137
drug therapy (134) 134
glucagon-like peptide-1 receptor (132) 132
hypoglycemic agents - administration & dosage (127) 127
blood glucose - drug effects (125) 125
glp-1 (123) 123
treatment outcome (122) 122
glucagon-like peptide 1 (119) 119
adult (115) 115
internal medicine (112) 112
hypoglycemic agents - adverse effects (111) 111
medicine, research & experimental (110) 110
research & experimental medicine (110) 110
biological and medical sciences (109) 109
rodents (108) 108
aged (106) 106
diabetes therapy (106) 106
care and treatment (105) 105
body weight (103) 103
diabetes mellitus, type 2 - blood (103) 103
diabetes mellitus, type 2 - metabolism (102) 102
body weight - drug effects (101) 101
obesity - drug therapy (101) 101
risk factors (101) 101
insulin resistance (99) 99
glucagon-like peptide-1 (97) 97
medical sciences (97) 97
receptors, glucagon - agonists (95) 95
peptides - therapeutic use (93) 93
blood glucose - metabolism (92) 92
health aspects (90) 90
peptides - pharmacology (90) 90
medicine & public health (89) 89
clinical trials (87) 87
mice, inbred c57bl (87) 87
venoms - therapeutic use (87) 87
liraglutide - administration & dosage (85) 85
physiological aspects (85) 85
glucagon-like peptide 1 - administration & dosage (84) 84
pharmacology (84) 84
disease models, animal (83) 83
venoms - pharmacology (80) 80
hypoglycemic agents (78) 78
dosage and administration (77) 77
weight loss (77) 77
glucagon-like peptide 1 - adverse effects (75) 75
weight loss - drug effects (75) 75
abridged index medicus (74) 74
endocrinology (73) 73
medical research (71) 71
insulin - metabolism (70) 70
dextrose (68) 68
diabetes mellitus, type 2 - physiopathology (68) 68
proteins (67) 67
metabolism (66) 66
signal transduction - drug effects (66) 66
type 2 diabetes mellitus (66) 66
apoptosis (65) 65
general & internal medicine (65) 65
weight control (65) 65
diabetes. impaired glucose tolerance (64) 64
dose-response relationship, drug (64) 64
endocrine pancreas. apud cells (64) 64
endocrinopathies (64) 64
medicine, general & internal (64) 64
biochemistry & molecular biology (63) 63
etiopathogenesis. screening. investigations. target tissue resistance (62) 62
neurosciences (61) 61
glucagon-like peptide 1 - metabolism (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1182) 1182
Japanese (10) 10
Chinese (9) 9
Spanish (8) 8
Italian (4) 4
Czech (2) 2
Danish (2) 2
French (2) 2
Hungarian (2) 2
German (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes (New York, N.Y.), ISSN 0012-1797, 04/2017, Volume 66, Issue 4, p. 1062
Anorexia | Receptor, Serotonin, 5-HT2C - metabolism | Body Weight - drug effects | Male | Weight Loss - drug effects | Pyrrolidines - pharmacology | Glucagon-Like Peptide-1 Receptor - metabolism | Liraglutide - pharmacology | Glucagon-Like Peptide-1 Receptor - drug effects | Indoles - pharmacology | Receptor, Serotonin, 5-HT2A - drug effects | Fenclonine - pharmacology | Receptor, Serotonin, 5-HT2C - drug effects | Glucagon-Like Peptide 1 - pharmacology | Appetite - drug effects | Rats | Serotonin Antagonists - pharmacology | Rats, Sprague-Dawley | Feeding Behavior - drug effects | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Animals | Dorsal Raphe Nucleus - metabolism | Aminopyridines - pharmacology | Serotonin - metabolism | Venoms - pharmacology | Receptor, Serotonin, 5-HT2A - metabolism | Care and treatment | Control | Brain diseases, Metabolic | Glucagon | Serotonin | Research | Health aspects | Weight gain | Appetite | Hormones | Peptides | Energy | Weight | Weight Loss/drug effects | Neurosciences | Glucagon-Like Peptide 1/pharmacology | 5-HT2C/drug effects/metabolism | Pyrrolidines/pharmacology | Indoles/pharmacology | Fenclonine/pharmacology | Sprague-Dawley | Dorsal Raphe Nucleus/metabolism | Peptides/pharmacology | Feeding Behavior/drug effects | Hypoglycemic Agents/pharmacology | Neurovetenskaper | Body Weight/drug effects | 5-HT2A/drug effects/metabolism | Liraglutide/pharmacology | Glucagon-Like Peptide-1 Receptor/drug effects/metabolism | Aminopyridines/pharmacology | Receptor | Serotonin/metabolism | Serotonin Antagonists/pharmacology | Appetite/drug effects | Venoms/pharmacology
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 05/2017, Volume 25, Issue 13, pp. 1549 - 1566
Journal Article
Pharmacology, ISSN 0031-7012, 08/2010, Volume 86, Issue 1, pp. 44 - 57
Review | Glycemic control | Diabetes | Incretin mimetics | Hypoglycemia | Dipeptyl peptidase type 4 inhibitor | Weight | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - adverse effects | Nitriles - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Pyrrolidines - adverse effects | Pyrazines - therapeutic use | Weight Loss - drug effects | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Adamantane - therapeutic use | Adult | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Adamantane - pharmacology | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - pharmacology | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Triazoles - pharmacology | Pyrazines - adverse effects | Venoms - therapeutic use | Venoms - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Nitriles - adverse effects | Pyrazines - pharmacology | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Nitriles - therapeutic use | Index Medicus
Journal Article
Cardiovascular drugs and therapy, ISSN 0920-3206, 10/2014, Volume 28, Issue 5, pp. 425 - 432
DPP-4 | PKC | Inflammation | GLP-1 | Medicine & Public Health | Cardiology | Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Pyrazines - antagonists & inhibitors | Tetradecanoylphorbol Acetate - pharmacology | Toll-Like Receptor 4 - biosynthesis | Nitriles - pharmacology | NLR Family, Pyrin Domain-Containing 3 Protein | Humans | Pyrrolidines - antagonists & inhibitors | Tetradecanoylphorbol Acetate - analogs & derivatives | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Inflammasomes - biosynthesis | Pyrrolidines - pharmacology | Protein Kinase C - metabolism | Interleukin-1beta - biosynthesis | Cell Culture Techniques | Nitriles - antagonists & inhibitors | Phosphorylation - drug effects | Sitagliptin Phosphate | Cyclic AMP-Dependent Protein Kinases - biosynthesis | Glucagon-Like Peptide 1 - analogs & derivatives | Carrier Proteins - biosynthesis | Glucagon-Like Peptide 1 - pharmacology | Receptors, Glucagon - metabolism | Triazoles - antagonists & inhibitors | Gene Expression Regulation - drug effects | Triazoles - pharmacology | Macrophages - metabolism | Carrier Proteins - metabolism | Glucagon-Like Peptide-1 Receptor | Signal Transduction - drug effects | Receptors, Glucagon - biosynthesis | Macrophages - drug effects | Pyrazines - pharmacology | Liraglutide | Peptides | Interleukins | Low density lipoproteins | Atherosclerosis | Macrophages | Protein kinases | Index Medicus
Journal Article